DOCSLIB.ORG

WHO Study Group on Tobacco Product Regulation

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
WHO Study Group on Tobacco Product Regulation WHO Technical Report Series 1029 WHO study group on tobacco product regulation Report on the scientific basis of tobacco product regulation: eighth report of a WHO study group WHO was established in 1948 as a specialized agency of the United Nations serving as the directing and coordinating authority for international health matters and public health. One of WHO’s constitutional functions is to provide objective, reliable information and advice in the field of human health, a responsibility that it fulfils in part through its extensive programme of publications. The Organization seeks through its publications to support national health strategies and address the most pressing public health concerns of populations around the world. To respond to the needs of Member States at all levels of development, WHO publishes practical manuals, handbooks and training material for specific categories of health workers; internationally applicable guidelines and standards; reviews and analyses of health policies, programmes and research; and state-of-the-art consensus reports that offer technical advice and recommendations for decision-makers. These publications are closely tied to the Organization’s priorities, which are to prevent and control disease and ensure equitable health systems based on primary health care and health promotion for individuals and communities. This includes strengthening implementation of the WHO Framework Convention on Tobacco Control (to meet Sustainable Development Goal 3a), thereby contributing to WHO’s priority of improving the lives of one billion individuals through enjoyment of better health and well-being. Progress towards better health for all requires global dissemination and exchange of information based on the knowledge and experience of all WHO’s Member States and on collaboration among world leaders in public health and the biomedical sciences. To ensure the widest possible availability of authoritative information and guidance on health matters, WHO ensures broad international distribution of its publications and encourages their translation and adaptation. By helping to promote and protect health and prevent and control disease throughout the world, WHO’s publications contribute to achieving the Organization’s principal objective – the attainment by all people of the highest possible level of health. The WHO Technical Report Series makes available the findings of international groups of experts who provide WHO with the latest scientific and technical advice on a broad range of medical and public health subjects. Members of such expert groups serve without remuneration, in their personal capacities rather than as representatives of governments or other bodies; their views do not necessarily reflect the decisions or the stated policy of WHO. For further information, please contact WHO Press, World Health Organization; 1211 Geneva 27, Switzerland; www.who.int/bookorders; tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: [email protected]. WHO Technical Report Series 1029 WHO study group on tobacco product regulation Report on the scientific basis of tobacco product regulation: eighth report of a WHO study group WHO study group on tobacco product regulation. Report on the scientific basis of tobacco product regulation: eighth report of a WHO study group (WHO Technical Report Series, No. 1029) ISBN 978-92-4-002272-0 (electronic version) ISBN 978-92-4-002273-7 (print version) ISSN 0512-3054 © World Health Organization 2021 Some rights reserved. This work is available under the Creative Commons Attribution-NonCommercial- ShareAlike 3.0 IGO licence (CC BY-NC-SA 3.0 IGO; https://creativecommons.org/licenses/by-nc-sa/3.0/igo). Under the terms of this licence, you may copy, redistribute and adapt the work for non-commercial purposes, provided the work is appropriately cited, as indicated below. In any use of this work, there should be no suggestion that WHO endorses any specific organization, products or services. The use of the WHO logo is not permitted. If you adapt the work, then you must license your work under the same or equivalent Creative Commons licence. If you create a translation of this work, you should add the following disclaimer along with the suggested citation: “This translation was not created by the World Health Organization (WHO). WHO is not responsible for the content or accuracy of this translation. The original English edition shall be the binding and authentic edition”. Any mediation relating to disputes arising under the licence shall be conducted in accordance with the mediation rules of the World Intellectual Property Organization. Suggested citation. WHO study group on tobacco product regulation. Report on the scientific basis of tobacco product regulation: eighth report of a WHO study group. Geneva: World Health Organization; 2021 (WHO Technical Report Series, No. 1029). Licence: CC BY-NC-SA 3.0 IGO. Cataloguing-in-Publication (CIP) data. CIP data are available at http://apps.who.int/iris. Sales, rights and licensing. To purchase WHO publications, see http://apps.who.int/bookorders. To submit requests for commercial use and queries on rights and licensing, see http://www.who.int/about/licensing. Third-party materials. If you wish to reuse material from this work that is attributed to a third party, such as tables, figures or images, it is your responsibility to determine whether permission is needed for that reuse and to obtain permission from the copyright holder. The risk of claims resulting from infringement of any third-party- owned component in the work rests solely with the user. General disclaimers. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by WHO in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by WHO to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall WHO be liable for damages arising from its use. This publication contains the collective views of an international group of experts and does not necessarily represent the decisions or the policies of WHO. Contents Participants in the 10th meeting of the WHO study group on tobacco product regulation ix Acknowledgements xiii Abbreviations and acronyms xiv 1. Introduction 1 2. Toxicants in heated tobacco products, exposure, health effects and claims of reduced risk 7 Abstract 7 2.1 Background 8 2.2 Toxicants in heated tobacco product (HTP) emissions 10 2.2.1 Laboratory methods for measuring toxicants 10 2.2.2 Nicotine 11 2.2.3 Other toxicants 13 2.3 Exposure and effects of HTPs in vitro and in laboratory animals 20 2.3.1 In-vitro studies 20 2.3.2 Studies in laboratory animals 22 2.4 Exposure of humans to toxicants in HTPs and implications for health 24 2.4.1 Product use and topography 24 2.4.2 Biomarkers of exposure and effect 25 2.4.3 Passive exposure 29 2.4.4 Impact on health outcomes 31 2.5 Review of the evidence for reduced risk or harm with use of HTPs 33 2.5.1 Harm reduction in the context of tobacco products 33 2.5.2 Claims of reduced risk 33 2.6 Summary and implications for public health 37 2.6.1 Summary of data 37 2.6.2 Implications for public health 39 2.7 Research gaps and priorities 40 2.8 Policy recommendations 41 2.9 References 41 3. The attractiveness and addictive potential of heated tobacco products: effects on perception and use and associated effects 49 Abstract 49 3.1 Background 50 3.2 Attractiveness of heated tobacco products (HTPs) 52 3.2.1 Definitions of attractiveness in the context of Articles 9 and 10 of the WHO FCTC 52 3.2.2 Attractive features of HTPs 52 3.2.3 What we can learn from ENDS and ENNDS and relevance to HTPs 56 3.3 Addictiveness of HTPs 57 3.3.1 Addictiveness 57 3.3.2 What can we learn from ENDS and ENNDS and relevance to HTPs 61 3.3.3 Overall abuse liability of HTPs 61 iii 3.4 Effects of the attractiveness and addictiveness of ENDS, ENNDS and HTPs on perceptions of risk and harm and use 62 3.4.1 Contributions of attractiveness and addictiveness to initiation, switching, complementing and quitting conventional tobacco products 62 3.4.2 Learning from ENDS and ENNDS and application to HTPs 63 3.5 Discussion 64 3.5.1 Behavioural implications of different patterns of use among different groups 64 3.5.2 Implications for public health 65 3.5.3 Research gaps, priorities and questions 66 3.5.4 Policy recommendations 67 3.6 Conclusions 68 3.7 References 68 Annex 3.1. Menthol concentrations in IQOS, cigarettes and JUUL products 74 4. Variations among heated tobacco products: considerations and implications 75 Abstract 75 4.1 Background 76 4.1.1 Overview 76 4.1.2 Decision FCTC/COP8(22) of the Conference of the Parties 76 4.1.3 Scope and objectives 76 4.2 Variations among products on the market 77 4.2.1 Overview of product categories and types 77 4.2.2 Variations among heated tobacco products 79 4.2.3 Market distribution of product types and categories 79 4.3 Characteristics and design features of products 81 4.3.1 Temperature profiles of products and operational capabilities 81 4.3.2 Battery characteristics 81 4.3.3 Properties of tobacco inserts, sticks and capsules 81 4.4 Content, emissions and general design of products 82 4.4.1 Content and emissions 82 4.4.2 Nicotine delivery 85 4.4.3 Risk profiles 85 4.4.4 Regulatory implications of the contents of heated tobacco products 86 4.4.5 Regulatory implications of emissions 87 4.5 Variations among products, manufacturers and selling points 88 4.5.1 Manufacturers and selling points 88 4.5.2 Implications for customer pulling power 89 4.6 Discussion 90 4.7 Conclusions 91 4.8 Research gaps, priorities and questions 92 4.9 Policy recommendations 92 4.10 References 94 5.
Load more

Recommended publications
  • Health Effects of Flavored Tobacco and Nicotine Products
    HEALTH EFFECTS OF FLAVORED TOBACCO AND NICOTINE PRODUCTS "Flavored cigarettes appeal to kids and disguise the bad taste of tobacco, but they are just as addictive as regular tobacco products and have the same harmful health effects," -- Mitch Zeller, Director of the Food and Drug Administration’s (FDA) Center for Tobacco Products 1 The Tobacco Control Act, which was signed into law in 2009, banned cigarettes that contained candy or fruit flavors, to reduce the likelihood of youth smoking and addiction to tobacco. However, menthol was excluded from this ban. Tobacco manufacturers have also found a way to skirt this law by selling flavored cigarettes labeled as cigars. To understand some of the potential health impacts of ending the sale of flavored tobacco, below are just some of the health effects of tobacco and nicotine: Menthol Cigarettes The Tobacco Products Scientific Advisory Committee 2011 report concluded that menthol cigarettes are no more or less toxic than are regular cigarettes, but the flavor’s cooling and anesthetic properties reduce the harshness of cigarette smoke, thereby increasing their appeal to new smokers. 2 However, menthol cigarettes are more difficult to quit than unflavored tobacco because menthol decreases the metabolism of nicotine and increases the amount of the addictive substance in the blood. 3 Health Effects of Tobacco Use Smoking leads to disease and disability and harms nearly every organ of the body. More than 16 million Americans are living with a disease caused by smoking. For every person who dies because of smoking, at least 30 people live with a serious smoking-related illness.
    [Show full text]
  • Pack Modifications Influence Perceptions of Menthol E-Cigarettes
    Pack Modifications Influence Perceptions of Menthol E-cigarettes Amy M. Cohn, PhD Amanda L. Johnson, MHS Haneen Abudayyeh, MPH Bonnie King, MHS Jess Wilhelm, PhD Objectives: Tobacco package colors and descriptors influence attitudes and intentions to use. This study examined the impact of flavor, color, and descriptors on electronic cigarette (e-cigarette) packages young adults’ perceptions of e-cigarettes. Methods: We recruited 2872 US participants ages 18-24 from Amazon Mechanical Turk (2018-2019) and randomized them to view one of 7 e-cigarette package images that varied by flavor (menthol vs tobacco), color (green or brown vs black and white), and descriptor (present vs absent). Models examined main and interactive effects of flavor, color, and descriptor on perceptions of appeal, harm, and addictiveness, and the moderating effects of product appeal. Results: Menthol e-cigarette packages were rated as more “attention grabbing,” “appetizing,” and “fun to use.” Perceptions of harm and addictiveness did not vary across package conditions. Interactions of menthol pack conditions with appeal emerged. Specifically, participants exposed to the green package with the menthol descriptor reported low e-cigarette harm perceptions across all levels of “attention grabbing” and “discour- ages use,” while those exposed to the green package without the menthol descriptor or the brown package with the tobacco descriptor reported lower harm perceptions as ratings of prod- uct appeal increased. Conclusions: Colors and descriptors on e-cigarette packaging influence product appeal and harm perceptions. Key words: flavored tobacco; menthol; e-cigarettes; young adults; perceived harm; perceived addictiveness; appeal; packaging; marketing; tobacco companies Tob Regul Sci.™ 2021;7(2):87-102 DOI: doi.org/10.18001/TRS.7.2.1 urveillance data show that the prevalence of bacco smoke or vapor, making it easier for new us- current e-cigarette use has increased signifi- ers to initiate tobacco use.
    [Show full text]
  • Tobacco Deal Sealed Prior to Global Finance Market Going up in Smoke
    marketwatch KEY DEALS Tobacco deal sealed prior to global finance market going up in smoke The global credit crunch which so rocked £5.4bn bridging loan with ABN Amro, Morgan deal. “It had become an auction involving one or Iinternational capital markets this summer Stanley, Citigroup and Lehman Brothers. more possible white knights,” he said. is likely to lead to a long tail of negotiated and In addition it is rescheduling £9.2bn of debt – Elliott said the deal would be part-funded by renegotiated deals and debt issues long into both its existing commitments and that sitting on a large-scale disposal of Rio Tinto assets worth the autumn. the balance sheet of Altadis – through a new as much as $10bn. Rio’s diamonds, gold and But the manifestation of a bad bout of the facility to be arranged by Citigroup, Royal Bank of industrial minerals businesses are now wobbles was preceded by some of the Scotland, Lehmans, Barclays and Banco Santander. reckoned to be favourites to be sold. megadeals that the equity market had been Finance Director Bob Dyrbus said: Financing the deal will be new underwritten expecting for much of the last two years. “Refinancing of the facilities is the start of a facilities provided by Royal Bank of Scotland, One such long awaited deal was the e16.2bn process that is not expected to complete until the Deutsche Bank, Credit Suisse and Société takeover of Altadis by Imperial Tobacco. first quarter of the next financial year. Générale, while Deutsche and CIBC are acting as Strategically the Imps acquisition of Altadis “Imperial Tobacco only does deals that can principal advisors on the deal with the help of has been seen as the must-do in a global generate great returns for our shareholders and Credit Suisse and Rothschild.
    [Show full text]
  • Environmental Assessment for a Marketing Order for a New Combusted, Filtered Cigarette Manufactured by Philip Morris USA Inc
    Environmental Assessment for a Marketing Order for a New Combusted, Filtered Cigarette Manufactured by Philip Morris USA Inc. Prepared by Center for Tobacco Products U.S. Food and Drug Administration May 7, 2019 Table of Contents 1. Applicant and Manufacturer Information .......................................................................................... 3 2. Product Information ............................................................................................................................ 3 3. The Need for the Proposed Action ...................................................................................................... 3 4. Alternative to the Proposed Action .................................................................................................... 3 5. Potential Environmental Impacts of the Proposed Action and Alternative - Manufacturing the New Product ............................................................................................................................................. 4 5.1 Affected Environment.. ....................................................................................................... 4 5.2 Air Quality ........................................................................................................................... 5 5.3 Water Resources ................................................................................................................. 5 5.4 Soil, Land Use, and Zoning .................................................................................................
    [Show full text]
  • Nicotine Replacement Therapy Using Medications to Help You Quit Smoking Can Double Your Chances of Quitting
    Boston Medical Center Tobacco Treatment Team Tips to Get the Most Benefit From Your Nicotine Replacement Therapy Using medications to help you quit smoking can double your chances of quitting. To gain the most benefit, nicotine patches are often used in combination with nicotine gum or lozenges. Continue to use the patch and gum/lozenge for at least 6 weeks or as prescribed. You may keep a few pieces of gum or lozenge to use in order to prevent a relapse after the six weeks. If you have any questions concerning your nicotine replacement medications, contact your health care provider, pharmacist or call the Tobacco Treatment line at 617 638 7665. NICOTINE PATCHES How to use Every morning, place a fresh patch on a hairless area of skin between your neck and waist Keep the patch on for a full 24 hours before removing. When you remove the old patch, place a new patch on a different area of skin. o Using the same area of skin can cause skin irritation or rash, so it is best to rotate sites. The patch sticks best when skin is clean and dry. o Avoid lotion/oils on skin where you will place patch, as this may prevent the patch from sticking. o Do not use on skin that has a rash or cut. Helpful hints Some people notice trouble sleeping or nightmares after starting the patch. o If you have these, try taking the patch off each night at bedtime. o Place a new patch in the morning. It is best to avoid smoking while using the patch.
    [Show full text]
  • Surveillance of U.S. Corporate Filings Provides a Proactive Approach to Inform Tobacco Regulatory Research Strategy
    Preprints (www.preprints.org) | NOT PEER-REVIEWED | Posted: 25 January 2021 doi:10.20944/preprints202101.0472.v1 Article Surveillance of U.S. corporate filings provides a proactive approach to inform tobacco regulatory research strategy S. Emma Sarles 1, Edward C. Hensel 2* and Risa J. Robinson 3 1 PhD in Engineering Student, Rochester Institute of Technology, Rochester NY, USA; [email protected], https://orcid.org/0000-0003-4890-1820 2 Department of Mechanical Engineering, Rochester Institute of Technology, Rochester NY, USA; [email protected], https://orcid.org/0000-0002-2682-0766 3 Department of Mechanical Engineering, Rochester Institute of Technology, Rochester NY, USA; [email protected], https://orcid.org/0000-0001-8488-5448 * Correspondence: [email protected] Abstract: The popularity of electronic cigarettes in the United States and around the world has led to a startling rise in youth nicotine use. The Juul e-cigarette was introduced in the U.S. market in 2015 and had captured approximately 13% of the U.S. market by 2017. Unlike many other contemporary electronic cigarette companies, the founders behind the Juul® e-cigarette approached their product launch like a traditional high-tech start-up company, not like a tobacco company. This article presents a case study of Juul’s corporate and product development history in the context of US regulatory actions. The objective of this article is to demonstrate the value of government- curated archives as leading indicators which can (a) provide insight into emergent technologies and (b) inform emergent regulatory science research questions. A variety of sources were used to gather data about the Juul e-cigarette and the corporations that surround it.
    [Show full text]
  • Tokyo 2020 Paralympic Games
    TOKYO 2020 PARALYMPIC GAMES QUALIFICATION REGULATIONS REVISED EDITION, APRIL 2021 INTERNATIONAL PARALYMPIC COMMITTEE 2 CONTENTS 1. Introduction 2. Tokyo 2020 Paralympic Games Programme Overview 3. General IPC Regulations on Eligibility 4. IPC Redistribution Policy of Vacant Qualification Slots 5. Universality Wild Cards 6. Key Dates 7. Archery 8. Athletics 9. Badminton 10. Boccia 11. Canoe 12. Cycling (Track and Road) 13. Equestrian 14. Football 5-a-side 15. Goalball 16. Judo 17. Powerlifting 18. Rowing 19. Shooting 20. Swimming 21. Table Tennis 22. Taekwondo 23. Triathlon 24. Volleyball (Sitting) 25. Wheelchair Basketball 26. Wheelchair Fencing 27. Wheelchair Rugby 28. Wheelchair Tennis 29. Glossary 30. Register of Updates INTERNATIONAL PARALYMPIC COMMITTEE 3 INTRODUCTION These Qualification Regulations (Regulations) describe in detail how athletes and teams can qualify for the Tokyo 2020 Paralympic Games in each of the twenty- two (22) sports on the Tokyo 2020 Paralympic Games Programme (Games Programme). It provides to the National Paralympic Committees (NPCs), to National Federations (NFs), to sports administrators, coaches and to the athletes themselves the conditions that allow participation in the signature event of the Paralympic Movement. These Regulations present: • an overview of the Games Programme; • the general IPC regulations on eligibility; • the specific qualification criteria for each sport (in alphabetical order); and • a glossary of the terminology used throughout the Regulations. STRUCTURE OF SPORT-SPECIFIC QUALIFICATION
    [Show full text]
  • Using the Nicotine Gum Using the Nicotine Gum Using the Nicotine Gum Using the Nicotine Gum
    Using the Nicotine Gum Using the Nicotine Gum Using the Nicotine Gum Using the Nicotine Gum Nicorette® is a sugar-free nicotine gum used to help smokers slowly get off Nicorette® is a sugar-free nicotine gum used to help smokers slowly get off Nicorette® is a sugar-free nicotine gum used to help smokers slowly get off Nicorette® is a sugar-free nicotine gum used to help smokers slowly get off nicotine.When chewed correctly, and used on a regular schedule, it supplies a nicotine.When chewed correctly, and used on a regular schedule, it supplies a nicotine.When chewed correctly, and used on a regular schedule, it supplies a nicotine.When chewed correctly, and used on a regular schedule, it supplies a steady stream of nicotine to the body through the lining of the mouth.This steady stream of nicotine to the body through the lining of the mouth.This steady stream of nicotine to the body through the lining of the mouth.This steady stream of nicotine to the body through the lining of the mouth.This may help reduce the withdrawal symptoms that occur during the first weeks may help reduce the withdrawal symptoms that occur during the first weeks may help reduce the withdrawal symptoms that occur during the first weeks may help reduce the withdrawal symptoms that occur during the first weeks of quitting smoking. of quitting smoking. of quitting smoking. of quitting smoking. Obtaining the Gum: its taste.The nicotine gets into your bloodstream Obtaining the Gum: its taste.The nicotine gets into your bloodstream Obtaining the Gum: its taste.The nicotine
    [Show full text]
  • Appendix 1: Codebook for “Content Analysis of E-Cigarette Products, Promotions, Prices and Claims on Internet Tobacco Vendor Websites, 2013-2014”
    Appendix 1: Codebook for “Content Analysis of E-cigarette Products, Promotions, Prices and Claims on Internet Tobacco Vendor Websites, 2013-2014” (The following is a succinct version of the codebook intended to provide definitions for each variable; the original codebook used for training and reference by coders includes extensive text and graphic examples) Appendix Table 1. Codebook for Products sold by Internet Tobacco Vendors Selling E-Cigarettes Product (Variable) Codebook Definition Disposable e-cigarettes Any e-cigarette intended to be used and disposed of rather than refilled with e- liquids or cartridges. E-cigarette starter kit A kit containing everything needed to start vaping with a refillable e-cigarette, including the vaping device, battery, charger, and e-liquid or refill cartridges. Electronic cigars (e-cigars) An e-cigarette specifically made to resemble a large cigar, must use the term cigar, e.g. e-cigar or electronic cigar. Disposable e-cigars A disposable e-cigarette specifically made to resemble a large cigar (and be disposed of rather than refilled), must use the term cigar, e.g. e-cigar or electronic cigar. Most popular retail store Whether IEVs sold the five most popular e-cigarette brands in retail stores at the e-cigarette brands time of data collection (Blu, Njoy, Mistic, 21st Century Smoke, and Logic) were tracked in 2013. In 2014, Mistic and 21st Century Smoke were dropped because they were not found at all at IEVs in our 2013 sample, and four other brands found to be the most popular in our study of Google Search Trends were added to our brand tracking in 2014 (Joyetech, Ego, Nucig, and V2).
    [Show full text]
  • Heated Cigarettes: How States Can Avoid Getting Burned
    HEATED CIGARETTES: HOW STATES CAN AVOID GETTING BURNED 8/30/18 1 HEATED CIGARETTES HOW STATES CAN AVOID GETTING BURNED 8/30/18 2 THE PUBLIC HEALTH LAW CENTER 8/30/18 3 8/30/18 4 LEGAL TECHNICAL ASSISTANCE Legal Research Policy Development, Implementation, Defense Publications Trainings Direct Representation Lobby 8/30/18 5 HEATED CIGARETTES HOW STATES CAN AVOID GETTING BURNED • Presenters: – Kristy Marynak, MPP, Public Health Analyst, Centers for Disease Control and Prevention – Hudson Kingston, JD, LLM, Staff Attorney, Tobacco Control Legal Consortium at the Public Health Law Center 8/30/18 6 HEATED CIGARETTES HOW STATES CAN AVOID GETTING BURNED • Heated cigarettes on the global market • Distinguishing features 1. Heating at a temperature lower than conventional cigarettes that produce an inhalable aerosol • Heated Cigarettes: 450-700° F (generally) • Conventional cigarettes: 1250 – 1300 °F, • (max: 1500 °F) 2. Processed, commercial tobacco leaf is the nicotine source, flavor source, or both 8/30/18 7 HEATED CIGARETTES HOW STATES CAN AVOID GETTING BURNED Federal Regulation • Pre-Market Review • Modified Risk Tobacco Product Application • Vapeleaf 8/30/18 8 Heated Tobacco Products: Considerations for Public Health Policy and Practice KRISTY MARYNAK, MPP LEAD PUBLIC HEALTH ANALYST CDC OFFICE ON SMOKING AND HEALTH TOBACCO CONTROL LEGAL CONSORTIUM WEBINAR AUGUST 2018 8/30/18 9 What’s the public health importance of this topic? The landscape of tobacco products is continually changing By being proactive and anticipating new products, we can
    [Show full text]
  • Robert K. Jackler Testimony.Pdf
    Brief Biography of Robert K. Jackler, MD: Dr. Jackler is a professor at the Stanford University School of Medicine and is a practicing surgeon. He is the founder and principal investigator of an interdisciplinary research group (Stanford Research Into The Impact of Tobacco Advertising or SRITA) which conducts research into the promotional activities of the tobacco industry. SRITA collected 56,600 original tobacco advertisements which were donated to the National Museum of American History of the Smithsonian Institution. A public exhibit at NMAH drawn from this collection opened in April 2019. SRITA maintains an extensive online tobacco advertising research database (tobacco.stanford.edu) which has over 813,000 unique users. As an academic research program, SRITA scholars conduct a wide spectrum of research into the promotional behaviors of the tobacco industry. SRITA focuses upon original scholarship utilizing the unique resource of our advertising collection. Our early academic focus was primarily an historical study of advertisements from the 20th century. In recent years, our research has focused upon the design and marketing of emerging tobacco products such as e-cigarettes (e.g. JUUL), heated tobacco (e.g. IQOS), and novel nicotine delivery systems. Our research is primarily designed to provide scientific data and analysis to inform regulators and legislators. SYNOPSIS OF OPINIONS: Today’s Tobacco Advertising Conveys the Same Messages as it Did in the 1950s: I suspect that most Americans think that the worst excesses of tobacco marketing lay in the 20th century when countless ads glorified smoking as glamorous and sexy and a worried public was reassured that “More Doctors Smoke Camels.” While the tobacco industry loudly claims they advertise ethically today, my in-depth study of tobacco advertising makes it clear that they still convey the same messages as during the earlier era.
    [Show full text]
  • Low-Nitrosamine Cigarettes Go on Sale
    Low-nitrosamine cigarettes go on sale ■ Star's Advance, which rette smoke. Advance cigarettes will also Star Scientific is the first tobacco com­ Dallas-Fort Worth. St.ax Scientific is t.aking contain reduced levels of such other toxins pany to sell low-nitrosamine cigarettes and a much different approach in marketing has lower levels of some as hydrogen cyanide, and their packaging the latest to market cigarettes that the Advance compared to RJR's marketing of will include detailed health warnings tak­ public might perceive as a safer smoking Eclipse. ' toxins, being test~marketed ing up the entire back of the cigarette alternative. Advance's two test markets are The c2mpany is making no health By Adrian Zawada packs. Richntond and Lexington, Ky. claims, admitting on its Advance cigarette JOURNAL REPORTER ''We have an obligation to make Advance R.J. Reynolds Tobacco Co. has invested packs that "there is not enough evidence St.ax Scientific Inc. began selling low­ available to adult tobacco consumers along more than $1 billion fu developing its available to know if Star's methods will nitrosamine cigarettes in selected Ken­ with infonnation about the comparable smokeless cigarette, Eclipse, and its failed actually lower your health risks." tucky and Virginia test markets yesterday toxic constituents of smoke," said Paul predecessor, Premier. RJR announced two weeks ago that com.; to attract smokers who want a cigarette Perito, the company's president and chair­ RJR's Eclipse heats tobacco instead of pany scientists found no reduction in the with less potential to cause cancer. man. "Star hopes that the start of its limit­ burning it, and the company says it might toxicity of low-nitrosamine tobacco when The cigarettes, called Advance, have 73 ed test market of Advance will serve as an present smokers with less risk of lung can­ exposing the smoke to animals and DNA percent less tobacco-specific ri.itrosamines incentive to the traditional tobacco indus­ cer, chronic bronchitis and emphysema.
    [Show full text]